Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2b study of PTC124 in nonsense-mutation Duchenne and Becker muscular dystrophy
2007-005478-29Phase 2Completed
- Sponsor
- PTC Therapeutics, Inc.
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ataluren in Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), sponsored by PTC Therapeutics, Inc.. Started Jan 2008; status: completed.
02
Drugs
ataluren
03
Conditions
Duchenne muscular dystrophy (DMD)Becker muscular dystrophy (BMD)
Beyond the preview
Go deeper on 2007-005478-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005478-29.